Subscribe To
3 of the top stocks to buy in october
October has gotten off to a good start, but there could still be volatility in the market. Here are three s...
October 10, 2021, 7:30 am
A trio of high ebitda margin stock picks
If you want to have a higher likelihood to find companies that are in good shape from a financial standpoint, you may want to consider the following <...
October 8, 2021, 11:07 am
A trio of high ebitda margin stock picks
If you want to have a higher likelihood to find companies that are in good shape from a financial standpoint, you may want to consider the following <...
October 8, 2021, 11:07 am
A trio of high ebitda margin stock picks
If you want to have a higher likelihood to find companies that are in good shape from a financial standpoint, you may want to consider the following <...
October 8, 2021, 11:07 am
These 3 no-brainer stocks were top performers this quarter. should you buy?
The market's recent slide has been a bummer. But there were at least three stocks that powered higher i...
October 8, 2021, 8:14 am
These 3 no-brainer stocks were top performers this quarter. should you buy?
The market's recent slide has been a bummer. But there were at least three stocks that powered higher i...
October 8, 2021, 8:14 am
These 3 no-brainer stocks were top performers this quarter. should you buy?
The market's recent slide has been a bummer. But there were at least three stocks that powered higher i...
October 8, 2021, 8:14 am
Clarion partners real estate income fund inc. (cpreif) closes on three strategically important acquisitions
SAN MATEO, Calif.--(BUSINESS WIRE)--Clarion Partners Real Estate Income Fund expands its property portfolio with diversifying acquisitions in Charlott...
October 7, 2021, 11:46 am
Clarion partners real estate income fund inc. (cpreif) closes on three strategically important acquisitions
SAN MATEO, Calif.--(BUSINESS WIRE)--Clarion Partners Real Estate Income Fund expands its property portfolio with diversifying acquisitions in Charlott...
October 7, 2021, 11:46 am
Clarion partners real estate income fund inc. (cpreif) closes on three strategically important acquisitions
SAN MATEO, Calif.--(BUSINESS WIRE)--Clarion Partners Real Estate Income Fund expands its property portfolio with diversifying acquisitions in Charlott...
October 7, 2021, 11:46 am
A trio of stocks with low peg ratios
When screening the market for bargain opportunities, investors may want to consider the three securitie...
October 6, 2021, 11:15 am
A trio of stocks with low peg ratios
When screening the market for bargain opportunities, investors may want to consider the three securitie...
October 6, 2021, 11:15 am
A trio of stocks with low peg ratios
When screening the market for bargain opportunities, investors may want to consider the three securitie...
October 6, 2021, 11:15 am
Kenorland minerals uncovers new multi-element anomaly at its chicobi project in quebec
Kenorland Minerals Ltd said it has identified a new anomaly at its Chicobi project in Quebec in a major underexplored structural break transecting t...
October 6, 2021, 10:59 am
Kenorland minerals uncovers new multi-element anomaly at its chicobi project in quebec
Kenorland Minerals Ltd said it has identified a new anomaly at its Chicobi project in Quebec in a major underexplored structural break transecting t...
October 6, 2021, 10:59 am
Kenorland minerals uncovers new multi-element anomaly at its chicobi project in quebec
Kenorland Minerals Ltd said it has identified a new anomaly at its Chicobi project in Quebec in a major underexplored structural break transecting t...
October 6, 2021, 10:59 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am